Skip to content
Subscriber Only

Insys Agrees to Pay $150 Million to Settle Opioid Sales Probe

Video player cover image
How America's Opioid Crisis Spiraled Out of Control

Pharmaceutical company Insys Therapeutics Inc. said it reached a $150 million settlement with the U.S. Department of Justice to resolve a civil and criminal probe into inappropriate sales of opioid-based painkillers by former employees.

The settlement will be paid over five years and could increase by as much as $75 million in contingency-based payments if certain unspecified events occur before the deal is finalized, the Chandler, Arizona-based company said Wednesday in a statement.